Irregular drug intake and serum chlorpropaminde concentrations
- PMID: 7428797
- DOI: 10.1007/BF00561584
Irregular drug intake and serum chlorpropaminde concentrations
Abstract
In patients with maturity onset diabetes serum chlorpropamide concentrations (s-CPA) and fasting blood glucose (FBG) were measured before and after self recording of drug intake in order to evaluate the role of compliance with the therapeutic regimen in variation in s-CPA and clinical outcome. Nine out of 57 patients (16%) had to be excluded because they did not comply with the clinical routines and the test procedure. Of the remaining 48 patients, only two recorded small deviations from the prescribed dosage, and nine (19%) noted variations in medication time of more than +/- 2h. By contrast, irregular drug intake was indicated in 29 of the 48 patients (60%) based on statistical evaluation of changes in s-CPA. Clinical control (FBG) was influenced significantly in only half of these 29 patients. Improved adherence to the dietary regimen was observed in 12 of the 48 patients (25%). Patient medication behaviour seems to be an important determination of variation in s-CPA, and is as important as adherence to the dietary regimen in clinical control of "drug requiring" patients with maturity onset diabetes.
Similar articles
-
Wide variation in serum chlorpropamide concentration in outpatients.Eur J Clin Pharmacol. 1980 Aug;18(2):165-9. doi: 10.1007/BF00561585. Eur J Clin Pharmacol. 1980. PMID: 7428798
-
Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.Br Med J. 1978 Jan 21;1(6106):142-4. doi: 10.1136/bmj.1.6106.142. Br Med J. 1978. PMID: 620227 Free PMC article.
-
Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.Pol J Pharmacol Pharm. 1984 Sep-Oct;36(5):449-53. Pol J Pharmacol Pharm. 1984. PMID: 6533629
-
Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.Diabetes Care. 1981 Mar-Apr;4(2):293-5. doi: 10.2337/diacare.4.2.293. Diabetes Care. 1981. PMID: 6783374
-
Interaction of rifampin and chlorpropamide.Chest. 1980 Jun;77(6):800-1. doi: 10.1378/chest.77.6.800. Chest. 1980. PMID: 7398394
Cited by
-
Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination.Eur J Clin Pharmacol. 1987;32(3):297-301. doi: 10.1007/BF00607578. Eur J Clin Pharmacol. 1987. PMID: 3595702
-
Patient medication on admission to a medical clinic.Eur J Clin Pharmacol. 1981;20(3):185-91. doi: 10.1007/BF00544596. Eur J Clin Pharmacol. 1981. PMID: 7286036 No abstract available.
-
Wide variation in serum chlorpropamide concentration in outpatients.Eur J Clin Pharmacol. 1980 Aug;18(2):165-9. doi: 10.1007/BF00561585. Eur J Clin Pharmacol. 1980. PMID: 7428798
-
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.Drugs. 1981 Oct;22(4):295-320. doi: 10.2165/00003495-198122040-00003. Drugs. 1981. PMID: 7030708 Review. No abstract available.
-
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.Clin Pharmacokinet. 1987 Jun;12(6):379-401. doi: 10.2165/00003088-198712060-00001. Clin Pharmacokinet. 1987. PMID: 3301149 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical